Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hyoungnam Lee"'
Autor:
Ji Eun Han, Min Kyu Park, Ju Hyun Jin, Jung Ah Lee, Gyeongsin Park, Jong Sook Park, Han-Ik Bae, Seok Joong Yun, An Na Seo, Man-Hoon Han, Hyoungnam Lee, Jae-Pil Jeon, Ji-In Yu, Soon Sun Kim, Jae Youn Cheong
Publikováno v:
Journal of Clinical Medicine. 12:3080
A control group is defined as a group of people used for comparison. Depending on the type of study, it can be a group of healthy people or a group not exposed to risk factors. It is important to allow researchers to select the appropriate control pa
Autor:
Yonggoo Kim, Goutam Nistala, Jun Kang, Youn Jin Choi, Jaeeun Yoo, Ahwon Lee, Hyoungnam Lee, Keun Ho Lee, Jongpill Choi, Myungshin Kim, Eunhee Han M.D, Charles Scafe, Youn Soo Lee
Publikováno v:
Pathology, research and practice. 215(11)
The detection of BRCA1/2 mutations is important because PARP1 inhibitors are approved for germline and/or somatic BRCA-mutated advanced ovarian cancer. Next-generation sequencing (NGS) is increasingly used in clinical practice for BRCA1/2 mutations.
Autor:
Ji Youl Lee, Kyoung Suk Kim, Yeong Jin Choi, Hyoungnam Lee, Tae Kon Hwang, Sung Hak Lee, Sung-Hoo Hong
Publikováno v:
Journal of Medical Virology. 86:347-353
Unlike the case for immunodeficient patients, little is known about polyomavirus (PV) infection in immunocompetent patients. PV infection in immunocompetent individuals has been reported sporadically, but little is known about asymptomatic hematuria.
Autor:
Jae-Lyun Lee, Jung Shin Lee, Tae-Won Kim, Byung Sik Kim, Sung Tae Oh, Heung Moon Chang, Se Jin Jang, Min-Hee Ryu, Hyoungnam Lee, Yoon-Koo Kang, Jeong Hwan Yook
Publikováno v:
Oncology. 74:88-95
Objective: Mutation of the PDGFRα is a potential candidate in the pathogenesis of KIT wild-type gastrointestinal tumors (GISTs). In this study, we evaluated the prevalence of PDGFRα mutations and corresponding protein expression in GISTs, to determ
Autor:
Woong-Shick Ahn, Gyung-Min Park, Jin Hyung Jung, Jae Mun Lee, Hyoungnam Lee, Bo-Mi Kim, Chang-Suk Kang
Publikováno v:
International Journal of Gynecological Cancer. 15:453-461
The initial aim of this study was to examine the expression profiles of P53 and its upstream genes, downstream genes, and cell cycle regulators to determine whether these markers are useful for making a differential diagnosis among the benign, border
Autor:
Dong Jun Lim, Gyeong Sin Park, Hyoungnam Lee, Ja Seong Bae, Min-Hee Kim, Chan Kwon Jung, So Ra Jeon
Publikováno v:
Endocrine-related cancer. 21(6)
The BRAF V600E mutation is the most common genetic alteration in thyroid cancer. However, its clinicopathological significance and clonal mutation frequency remain unclear. To clarify the inconsistent results, we investigated the association between
Autor:
Sung-Joo Kim Yoon, Choun-Ki Joo, Eunice Lee, Stephanie Lau, Angela Huebner, Hyoungnam Lee, Raju Kucherlapati, Young Seomun, Eunkyung Choi, Kate Montgomery
Publikováno v:
Genome Research. 10:1561-1567
The chromosome 12q13 (ch12q13) region of the human chromosome has been implicated in many diseases as well as various chromosomal anomalies. The region is linked to numerous inherited genetic diseases including keratin-associated diseases, triple A s
Autor:
Sung Hak, Lee, Sung Hoo, Hong, Ji Youl, Lee, Tae Kon, Hwang, Kyoung Suk, Kim, Hyoungnam, Lee, Yeong Jin, Choi
Publikováno v:
Journal of medical virology. 86(2)
Unlike the case for immunodeficient patients, little is known about polyomavirus (PV) infection in immunocompetent patients. PV infection in immunocompetent individuals has been reported sporadically, but little is known about asymptomatic hematuria.
Autor:
Hye-Sook Chang, Jungmin Jo, Jae-Gook Shin, Hyoungnam Lee, J.-L. Lee, Ho-Sook Kim, Tark Kim, Y-K. Kang, Min-Hee Ryu, Min Seon Kim
Publikováno v:
British Journal of Cancer
Background: To assess the efficacy and safety of individualised dose optimisation of irinotecan monotherapy as salvage treatment for advanced gastric cancer (AGC). Methods: A total of 43 patients were enrolled. Intravenous irinotecan (350 mg m−2) w
Autor:
Sung Sook Lee, Yoon-Koo Kang, Min-Hee Ryu, Hyoungnam Lee, Jae-Lyun Lee, Tae Won Kim, Sun Jin Sym, Geundoo Jang, Heung Moon Chang, Inkeun Park
Publikováno v:
Japanese journal of clinical oncology. 39(2)
Objective: We evaluated the results of imatinib dose escalation in patients with advanced gastrointestinal stromal tumors (GISTs) after disease progression on standard-dose imatinib. Methods: Clinical data from patients with metastatic or unresectabl